NCT00332579View on ClinicalTrials.gov

Double-Blind Naltrexone in Kleptomania

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 1, 2006

Primary Completion Date

September 1, 2008

Study Completion Date

September 1, 2008

Conditions
Kleptomania
Interventions
DRUG

Naltrexone

daily

DRUG

Placebo

daily

Trial Locations (1)

55454

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT00332579 - Double-Blind Naltrexone in Kleptomania | Biotech Hunter | Biotech Hunter